News & Updates

A recent study has shown the importance of identifying and treating aberrant peripheral and central pain regulation in patients with rheumatoid arthritis (RA) who are either initiating or switching to disease-modifying antirheumatic drug (DMARD) treatment.

Patients with juvenile fibromyalgia syndrome (JFS) often complain of sleep problems, which have a significant impact on clinical domains of the disease, including depression and pain, reports a study.

Adolescents with juvenile idiopathic arthritis (JIA) remain vulnerable to symptoms of depression and anxiety, particularly panic, according to a study, noting the ongoing need for mental health screening protocols and services in this population.

Treatment with brepocitinib at 30 and 60 mg daily outperforms placebo at relieving signs and symptoms of psoriatic arthritis (PsA), with a safety profile consistent with that seen in other brepocitinib trials, according to data from a phase IIb study.

Vaccination with either BNT162b2 or mRNA-1273 results in a comparable risk of breakthrough COVID-19 infection among patients with systemic autoimmune rheumatic diseases (SARDs) using immunomodulatory medication, a study has shown.

Higher levels of fibromyalgia (FM) symptoms in patients with rheumatoid arthritis (RA) are slightly indicative of worse disease activity following treatment with a disease-modifying antirheumatic drug (DMARD), suggest the results a recent study.

The occurrence of sarcoidosis in patients with systemic sclerosis (SSc) is rare but seems to be more frequent when compared to the general population, reveals a study.